Picture of Calliditas Therapeutics AB logo

CALTX — Calliditas Therapeutics AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareMid Cap

Brief: Calliditas Therapeutics AB Reports PDUFA Goal Date Extension For Nefecon NDA In U.S.

Sept 14 (Reuters) - Calliditas Therapeutics AB  CALTX.ST :
    * CALLIDITAS THERAPEUTICS AB  CALTX.ST  - PDUFA GOAL DATE
EXTENSION FOR NEFECON NDA IN U.S.
    * CALLIDITAS THERAPEUTICS AB  CALTX.ST  - FDA HAS EXTENDED
PDUFA
GOAL DATE TO DECEMBER 15, 2021 
    * CALLIDITAS THERAPEUTICS AB -IN ITS REVIEW OF NDA, FDA HAS
REQUESTED FURTHER ANALYSES OF NEFLGARD TRIAL DATA WHICH CO HAS
PROVIDED TO FDA 

Source text for Eikon:  ID:nWkrc2FVBc 
Further company coverage:  CALTX.ST 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Calliditas Therapeutics AB

See all news